Compare MOD & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOD | SNN |
|---|---|---|
| Founded | 1916 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Auto Parts:O.E.M. | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 14.3B |
| IPO Year | 1995 | N/A |
| Metric | MOD | SNN |
|---|---|---|
| Price | $228.69 | $30.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $223.71 | $36.25 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 05-19-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.26 | N/A |
| Revenue | ★ $1,352,500,000.00 | N/A |
| Revenue This Year | $23.05 | $8.58 |
| Revenue Next Year | $21.83 | $5.60 |
| P/E Ratio | $102.30 | ★ $64.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $86.48 | $28.56 |
| 52 Week High | $323.25 | $38.79 |
| Indicator | MOD | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 50.98 |
| Support Level | $230.61 | $29.19 |
| Resistance Level | $238.19 | $31.06 |
| Average True Range (ATR) | 16.39 | 0.53 |
| MACD | -5.98 | -0.04 |
| Stochastic Oscillator | 7.43 | 75.84 |
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.